Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 27 November 1998:
Vol. 282. no. 5394, pp. 1714 - 1717
DOI: 10.1126/science.282.5394.1714
Prev | Table of Contents | Next

Reports

Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)

Jian-Jun Chen, Yongnian Sun, Gary J. Nabel *

Fas ligand (CD95L) inhibits T cell function in immune-privileged organs such as the eye and testis, yet in most tissues CD95L expression induces potent inflammatory responses. With a stably transfected colon carcinoma cell line, CT26-CD95L, the molecular basis for these divergent responses was defined. When injected subcutaneously, rejection of CT26-CD95L was caused by neutrophils activated by CD95L. CT26-CD95L survived in the intraocular space because of the presence of transforming growth factor-beta (TGF-beta ), which inhibited neutrophil activation. Providing TGF-beta to subcutaneous sites protected against tumor rejection. Thus, these cytokines together generate a microenvironment that promotes immunologic tolerance, which may aid in the amelioration of allograft rejection.

Howard Hughes Medical Institute, University of Michigan Medical Center, Departments of Internal Medicine and Biological Chemistry, 1150 West Medical Center Drive, 4520 Medical Science Research Building I, Ann Arbor, MI 48109-0650, USA.
*   To whom correspondence should be addressed. E-mail: gnabel{at}umich.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
S. Buonocore, N. O. Haddou, F. Moore, S. Florquin, F. Paulart, C. Heirman, K. Thielemans, M. Goldman, and V. Flamand (2008)
J. Leukoc. Biol. 84, 713-720
   Abstract »    Full Text »    PDF »
Expression of a Soluble TGF-{beta} Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy.
M. Zhang, B. E. Berndt, J.-J. Chen, and J. Y. Kao (2008)
J. Immunol. 181, 3690-3697
   Abstract »    Full Text »    PDF »
Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
A. Kaponis, A. Skyrlas, N. Zagorianakou, I. Georgiou, V. Passa, E. Paraskevaidis, and G. Makrydimas (2008)
Hum. Reprod. 23, 1159-1169
   Abstract »    Full Text »    PDF »
Intratumoral Delivery and Suppression of Prostate Tumor Growth by Attenuated Salmonella enterica serovar typhimurium Carrying Plasmid-Based Small Interfering RNAs.
L. Zhang, L. Gao, L. Zhao, B. Guo, K. Ji, Y. Tian, J. Wang, H. Yu, J. Hu, D. V. Kalvakolanu, et al. (2007)
Cancer Res. 67, 5859-5864
   Abstract »    Full Text »    PDF »
Loss of Functional Fas Ligand Enhances Intestinal Tumorigenesis in the Min Mouse Model.
B. Fingleton, K. J. Carter, and L. M. Matrisian (2007)
Cancer Res. 67, 4800-4806
   Abstract »    Full Text »    PDF »
Enhanced Antitumor Responses Elicited by Combinatorial Protein Transfer of Chemotactic and Costimulatory Molecules.
S. Liu, D. R. Breiter, G. Zheng, and A. Chen (2007)
J. Immunol. 178, 3301-3306
   Abstract »    Full Text »    PDF »
Depleting Intratumoral CD4+CD25+ Regulatory T Cells via FasL Protein Transfer Enhances the Therapeutic Efficacy of Adoptive T Cell Transfer.
A. Chen, S. Liu, D. Park, Y. Kang, and G. Zheng (2007)
Cancer Res. 67, 1291-1298
   Abstract »    Full Text »    PDF »
Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation..
P. Zamiri, S. Masli, J. W. Streilein, and A. W. Taylor (2006)
Invest. Ophthalmol. Vis. Sci. 47, 3912-3918
   Abstract »    Full Text »    PDF »
Roles of Apoptosis in Airway Epithelia.
Y. Tesfaigzi (2006)
Am. J. Respir. Cell Mol. Biol. 34, 537-547
   Abstract »    Full Text »    PDF »
The Role of Apoptosis in the Regulation of Trophoblast Survival and Differentiation during Pregnancy.
S. L. Straszewski-Chavez, V. M. Abrahams, and G. Mor (2005)
Endocr. Rev. 26, 877-897
   Abstract »    Full Text »    PDF »
Addressing the "Fas Counterattack" Controversy: Blocking Fas Ligand Expression Suppresses Tumor Immune Evasion of Colon Cancer In vivo.
A. E. Ryan, F. Shanahan, J. O'Connell, and A. M. Houston (2005)
Cancer Res. 65, 9817-9823
   Abstract »    Full Text »    PDF »
Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines.
Z. Guo, M. Zhang, H. Tang, and X. Cao (2005)
Blood 106, 2033-2041
   Abstract »    Full Text »    PDF »
A Novel Treatment for Ocular Tumors Using Membrane FasL Vesicles to Activate Innate Immunity and Terminate Immune Privilege.
M. S. Gregory, S. Koh, E. Huang, R. R. Saff, A. Marshak-Rothstein, S. Mukai, and B. R. Ksander (2005)
Invest. Ophthalmol. Vis. Sci. 46, 2495-2502
   Abstract »    Full Text »    PDF »
Secreted Protein Acidic and Rich in Cysteine Produced by Human Melanoma Cells Modulates Polymorphonuclear Leukocyte Recruitment and Antitumor Cytotoxic Capacity.
M. J. Alvarez, F. Prada, E. Salvatierra, A. I. Bravo, V. P. Lutzky, C. Carbone, F. J. Pitossi, H. E. Chuluyan, and O. L. Podhajcer (2005)
Cancer Res. 65, 5123-5132
   Abstract »    Full Text »    PDF »
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
G. Dotti, B. Savoldo, M. Pule, K. C. Straathof, E. Biagi, E. Yvon, S. Vigouroux, M. K. Brenner, and C. M. Rooney (2005)
Blood 105, 4677-4684
   Abstract »    Full Text »    PDF »
Testicular Immune Privilege Promotes Transplantation Tolerance by Altering the Balance between Memory and Regulatory T Cells.
I. W. Nasr, Y. Wang, G. Gao, S. Deng, L. Diggs, D. M. Rothstein, G. Tellides, F. G. Lakkis, and Z. Dai (2005)
J. Immunol. 174, 6161-6168
   Abstract »    Full Text »    PDF »
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.
D. J. Brat, A. C. Bellail, and E. G. Van Meir (2005)
Neuro-oncol 7, 122-133
   Abstract »    PDF »
Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells.
H. Li, J. Y. Niederkorn, S. Neelam, E. Mayhew, R. A. Word, J. P. McCulley, and H. Alizadeh (2005)
Invest. Ophthalmol. Vis. Sci. 46, 900-907
   Abstract »    Full Text »    PDF »
Induction of tolerance using Fas ligand: a double-edged immunomodulator.
N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan (2005)
Blood 105, 1396-1404
   Abstract »    Full Text »    PDF »
Profiling Tumor Counterattack: Do Fas Ligand-Containing Microvesicles Reduce Anticancer Immunity?.
O. Bohana-Kashtan and C. I. Civin (2005)
Clin. Cancer Res. 11, 968-970
   Full Text »    PDF »
Impaired Recall of CD8 Memory T Cells in Immunologically Privileged Tissue.
Z. Dai, I. W. Nasr, M. Reel, S. Deng, L. Diggs, C. P. Larsen, D. M. Rothstein, and F. G. Lakkis (2005)
J. Immunol. 174, 1165-1170
   Abstract »    Full Text »    PDF »
Lumican Regulates Corneal Inflammatory Responses by Modulating Fas-Fas Ligand Signaling.
N. Vij, L. Roberts, S. Joyce, and S. Chakravarti (2005)
Invest. Ophthalmol. Vis. Sci. 46, 88-95
   Abstract »    Full Text »    PDF »
cFLIPL Inhibits Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated NF-{kappa}B Activation at the Death-inducing Signaling Complex in Human Keratinocytes.
T. Wachter, M. Sprick, D. Hausmann, A. Kerstan, K. McPherson, G. Stassi, E.-B. Brocker, H. Walczak, and M. Leverkus (2004)
J. Biol. Chem. 279, 52824-52834
   Abstract »    Full Text »    PDF »
Involvement of IL-17 in Fas ligand-induced inflammation.
M. Umemura, T. Kawabe, K. Shudo, H. Kidoya, M. Fukui, M. Asano, Y. Iwakura, G. Matsuzaki, R. Imamura, and T. Suda (2004)
Int. Immunol. 16, 1099-1108
   Abstract »    Full Text »    PDF »
Endothelial Overexpression of Fas Ligand Decreases Atherosclerosis in Apolipoprotein E-Deficient Mice.
J. Yang, K. Sato, T. Aprahamian, N. J. Brown, J. Hutcheson, A. Bialik, H. Perlman, and K. Walsh (2004)
Arterioscler Thromb Vasc Biol 24, 1466-1473
   Abstract »    Full Text »    PDF »
CD95 Ligand Expression on Corneal Epithelium and Endothelium Influences the Fates of Orthotopic and Heterotopic Corneal Allografts in Mice.
H. Osawa, K. Maruyama, and J. W. Streilein (2004)
Invest. Ophthalmol. Vis. Sci. 45, 1908-1915
   Abstract »    Full Text »    PDF »
TGF-{beta}1 Represses Activation and Resultant Death of Microglia via Inhibition of Phosphatidylinositol 3-Kinase Activity.
W.-K. Kim, S.-Y. Hwang, E.-S. Oh, H. Z. Piao, K.-W. Kim, and I.-O. Han (2004)
J. Immunol. 172, 7015-7023
   Abstract »    Full Text »    PDF »
T Cell-specific Ablation of Fas Leads to Fas Ligand-mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis.
Z. Hao, B. Hampel, H. Yagita, and K. Rajewsky (2004)
J. Exp. Med. 199, 1355-1365
   Abstract »    Full Text »    PDF »
The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse.
A. Canbay, A. Feldstein, E. Baskin-Bey, S. F. Bronk, and G. J. Gores (2004)
J. Pharmacol. Exp. Ther. 308, 1191-1196
   Abstract »    Full Text »    PDF »
Effects of TGF-{beta}2 on Immune Response-Related Gene Expression Profiles in the Human Corneal Endothelium.
S. Yamagami, S. Yokoo, T. Mimura, and S. Amano (2004)
Invest. Ophthalmol. Vis. Sci. 45, 515-521
   Abstract »    Full Text »    PDF »
First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis.
V. M. Abrahams, S. L. Straszewski-Chavez, S. Guller, and G. Mor (2004)
Mol. Hum. Reprod. 10, 55-63
   Abstract »    Full Text »    PDF »
Fas ligation induces IL-1{beta}-dependent maturation and IL-1{beta}-independent survival of dendritic cells: different roles of ERK and NF-{kappa}B signaling pathways.
Z. Guo, M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao (2003)
Blood 102, 4441-4447
   Abstract »    Full Text »    PDF »
Fibronectin-Associated Fas Ligand Rapidly Induces Opposing and Time-Dependent Effects on the Activation and Apoptosis of T Cells.
A. Zanin-Zhorov, R. Hershkoviz, I. Hecht, L. Cahalon, and O. Lider (2003)
J. Immunol. 171, 5882-5889
   Abstract »    Full Text »    PDF »
Epithelial Ovarian Cancer Cells Secrete Functional Fas Ligand.
V. M. Abrahams, S. L. Straszewski, M. Kamsteeg, B. Hanczaruk, P. E. Schwartz, T. J. Rutherford, and G. Mor (2003)
Cancer Res. 63, 5573-5581
   Abstract »    Full Text »    PDF »
Fas Ligand on Tumor Cells Mediates Inactivation of Neutrophils.
Y.-L. Chen, S.-H. Chen, J.-Y. Wang, and B.-C. Yang (2003)
J. Immunol. 171, 1183-1191
   Abstract »    Full Text »    PDF »
Regulation of FasL/Fas in Human Trophoblasts: Possible Implications for Chorioamnionitis.
D. R Balkundi, J. A Ziegler, J. F Watchko, C. Craven, and M. Trucco (2003)
Biol Reprod 69, 718-724
   Abstract »    Full Text »    PDF »
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
G. Q. Phan, J. C. Yang, R. M. Sherry, P. Hwu, S. L. Topalian, D. J. Schwartzentruber, N. P. Restifo, L. R. Haworth, C. A. Seipp, L. J. Freezer, et al. (2003)
PNAS 100, 8372-8377
   Abstract »    Full Text »    PDF »
By Altering Ocular Immune Privilege, Bone Marrow-derived Cells Pathogenically Contribute to DBA/2J Pigmentary Glaucoma.
J.-S. Mo, M. G. Anderson, M. Gregory, R. S. Smith, O. V. Savinova, D. V. Serreze, B. R. Ksander, J. W. Streilein, and S. W.M. John (2003)
J. Exp. Med. 197, 1335-1344
   Abstract »    Full Text »    PDF »
Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart.
J. Yang, S. P. Jones, T. Suhara, J. J. M. Greer, P. D. Ware, N. P. Nguyen, H. Perlman, D. P. Nelson, D. J. Lefer, and K. Walsh (2003)
J. Biol. Chem. 278, 15185-15191
   Abstract »    Full Text »    PDF »
Single-Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen-Activated Protein Kinase Inhibitor: A First-in-Human Study.
D. A. Parasrampuria, P. de Boer, D. Desai-Krieger, A. T. Chow, and C. R. Jones (2003)
J. Clin. Pharmacol. 43, 406-413
   Abstract »    Full Text »    PDF »
Display of Fas Ligand Protein on Cardiac Vasculature as a Novel Means of Regulating Allograft Rejection.
N. Askenasy, E. S. Yolcu, Z. Wang, and H. Shirwan (2003)
Circulation 107, 1525-1531
   Abstract »    Full Text »    PDF »
Successful Intra- and Interspecific Male Germ Cell Transplantation in the Rat.
Z. Zhang, M. B. Renfree, and R. V. Short (2003)
Biol Reprod 68, 961-967
   Abstract »    Full Text »    PDF »
Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo.
S. Buonocore, F. Paulart, A. Le Moine, M. Braun, I. Salmon, S. Van Meirvenne, K. Thielemans, M. Goldman, and V. Flamand (2003)
Blood 101, 1469-1476
   Abstract »    Full Text »    PDF »
A Novel Signaling Mechanism for Soluble CD95 Ligand. SYNERGY WITH ANTI-CD95 MONOCLONAL ANTIBODIES FOR APOPTOSIS AND NF-kappa B NUCLEAR TRANSLOCATION.
S. Xiao, S. Jodo, S.-s. J. Sung, A. Marshak-Rothstein, and S.-T. Ju (2002)
J. Biol. Chem. 277, 50907-50913
   Abstract »    Full Text »    PDF »
Engagement of Na,K-ATPase {beta}3 subunit by a specific mAb suppresses T and B lymphocyte activation.
S. Chiampanichayakul, A. Szekeres, P. Khunkaewla, S. Moonsom, V. Leksa, K. Drbal, G. J. Zlabinger, R. Hofer-Warbinek, H. Stockinger, and W. Kasinrerk (2002)
Int. Immunol. 14, 1407-1414
   Abstract »    Full Text »    PDF »
Tumor Necrosis Factor alpha Up-regulates Non-lymphoid Fas-ligand following Superantigen-induced Peripheral Lymphocyte Activation.
M. J. Pinkoski, N. M. Droin, and D. R. Green (2002)
J. Biol. Chem. 277, 42380-42385
   Abstract »    Full Text »    PDF »
Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.
K. A. Whartenby, E. E. Straley, H. Kim, F. Racke, V. Tanavde, K. S. Gorski, L. Cheng, D. M. Pardoll, and C. I. Civin (2002)
Blood 100, 3147-3154
   Abstract »    Full Text »    PDF »
Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege.
M. S. Gregory, A. C. Repp, A. M. Holhbaum, R. R. Saff, A. Marshak-Rothstein, and B. R. Ksander (2002)
J. Immunol. 169, 2727-2735
   Abstract »    Full Text »    PDF »
Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis.
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader (2002)
J. Immunol. 169, 1561-1569
   Abstract »    Full Text »    PDF »
TGF-{beta}1 as an Enhancer of Fas-Mediated Apoptosis of Lung Epithelial Cells.
N. Hagimoto, K. Kuwano, I. Inoshima, M. Yoshimi, N. Nakamura, M. Fujita, T. Maeyama, and N. Hara (2002)
J. Immunol. 168, 6470-6478
   Abstract »    Full Text »    PDF »
Immune escape of tumors: apoptosis resistance and tumor counterattack.
F. H. Igney and P. H. Krammer (2002)
J. Leukoc. Biol. 71, 907-920
   Abstract »    Full Text »    PDF »
Differential Regulation and Function of the Fas/Fas Ligand System in Human Trophoblast Cells.
S. Aschkenazi, S. Straszewski, K. M.A. Verwer, H. Foellmer, T. Rutherford, and G. Mor (2002)
Biol Reprod 66, 1853-1861
   Abstract »    Full Text »    PDF »
Cellular Localization and Function of Fas Ligand (CD95L) in Tumors.
M. Kurooka, G. J. Nuovo, M. A. Caligiuri, and G. J. Nabel (2002)
Cancer Res. 62, 1261-1265
   Abstract »    Full Text »    PDF »
Increased plasma levels of the soluble form of fas ligand in patients with acute myocardial infarction and unstable angina pectoris.
M. Shimizu, K. Fukuo, S. Nagata, T. Suhara, M. Okuro, K. Fujii, Y. Higashino, M. Mogi, Y. Hatanaka, and T. Ogihara (2002)
J. Am. Coll. Cardiol. 39, 585-590
   Abstract »    Full Text »    PDF »
Viral IFN-Regulatory Factors Inhibit Activation-Induced Cell Death Via Two Positive Regulatory IFN-Regulatory Factor 1-Dependent Domains in the CD95 Ligand Promoter.
S. Kirchhoff, T. Sebens, S. Baumann, A. Krueger, R. Zawatzky, M. Li-Weber, E. Meinl, F. Neipel, B. Fleckenstein, and P. H. Krammer (2002)
J. Immunol. 168, 1226-1234
   Abstract »    Full Text »    PDF »
Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma.
J. F. Toso, V. J. Gill, P. Hwu, F. M. Marincola, N. P. Restifo, D. J. Schwartzentruber, R. M. Sherry, S. L. Topalian, J. C. Yang, F. Stock, et al. (2002)
J. Clin. Oncol. 20, 142-152
   Abstract »    Full Text »    PDF »
Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors.
A. M. Hohlbaum, M. S. Gregory, S.-T. Ju, and A. Marshak-Rothstein (2001)
J. Immunol. 167, 6217-6224
   Abstract »    Full Text »    PDF »
p38-mediated Regulation of an Fas-associated Death Domain Protein-independent Pathway Leading to Caspase-8 Activation during TGFbeta -induced Apoptosis in Human Burkitt Lymphoma B Cells BL41.
N. Schrantz, M.-F. Bourgeade, S. Mouhamad, G. Leca, S. Sharma, and A. Vazquez (2001)
Mol. Biol. Cell 12, 3139-3151
   Abstract »    Full Text »    PDF »
Regulation of Fas Ligand-Induced Apoptosis by TNF.
B. D. Elzey, T. S. Griffith, J. M. Herndon, R. Barreiro, J. Tschopp, and T. A. Ferguson (2001)
J. Immunol. 167, 3049-3056
   Abstract »    Full Text »    PDF »
FAS Ligand Triggers Pulmonary Silicosis.
V. M. Borges, H. Falcao, J. H. Leite-Junior, L. Alvim, G. P. Teixeira, M. Russo, A. F. Nobrega, M. F. Lopes, P. M. Rocco, W. F. Davidson, et al. (2001)
J. Exp. Med. 194, 155-164
   Abstract »    Full Text »    PDF »
Fas Ligand Overexpression on Allograft Endothelium Inhibits Inflammatory Cell Infiltration and Transplant-Associated Intimal Hyperplasia.
M. Sata, Z. Luo, and K. Walsh (2001)
J. Immunol. 166, 6964-6971
   Abstract »    Full Text »    PDF »
Fas-induced Expression of Chemokines in Human Glioma Cells: Involvement of Extracellular Signal-regulated Kinase 1/2 and p38 Mitogen-activated Protein Kinase.
C. Choi, X. Xu, J.-W. Oh, S. J. Lee, G. Y. Gillespie, H. Park, H. Jo, and E. N. Benveniste (2001)
Cancer Res. 61, 3084-3091
   Abstract »    Full Text »
Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100.
R. P. M. Sutmuller, L. R. H. M. Schurmans, L. M. van Duivenvoorde, J. A. Tine, E. I. H. van der Voort, R. E. M. Toes, C. J. M. Melief, M. J. Jager, and R. Offringa (2000)
J. Immunol. 165, 7308-7315
   Abstract »    Full Text »    PDF »
Retinoblastoma Protein Activation of Interleukin 8 Expression Inhibits Tumor Cell Survival in Nude Mice.
H. Zhang, S. Wei, J. Sun, D. Coppola, B. Zhong, G. D. Wu, B. Goodwin, S. Sebti, J. Y. Djeu, and G. Blanck (2000)
Cell Growth Differ. 11, 635-639
   Abstract »    Full Text »
Fas and Fas Ligand Expressed on Cells of the Immune System, not on the Target Tissue, Control Induction of Experimental Autoimmune Uveitis.
J. L. Wahlsten, H. L. Gitchell, C.-C. Chan, B. Wiggert, and R. R. Caspi (2000)
J. Immunol. 165, 5480-5486
   Abstract »    Full Text »    PDF »
Contribution of CD95 Ligand-Induced Neutrophil Infiltration to the Bystander Effect in p53 Gene Therapy for Human Cancer.
T. Waku, T. Fujiwara, J. Shao, T. Itoshima, T. Murakami, M. Kataoka, S. Gomi, J. A. Roth, and N. Tanaka (2000)
J. Immunol. 165, 5884-5890
   Abstract »    Full Text »    PDF »
Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.
M. D. Josephs, F. R. Bahjat, K. Fukuzuka, R. Ksontini, C. C. Solorzano, C. K. Edwards III, C. L. Tannahill, S. L. D. MacKay, E. M. Copeland III, and L. L. Moldawer (2000)
Am J Physiol Regulatory Integrative Comp Physiol 278, R1196-R1201
   Abstract »    Full Text »    PDF »
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152).
M. D. Griffin, D. K. Hong, P. O. Holman, K.-M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, et al. (2000)
J. Immunol. 164, 4433-4442
   Abstract »    Full Text »    PDF »
Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival.
A. M. Hohlbaum, S. Moe, and A. Marshak-Rothstein (2000)
J. Exp. Med. 191, 1209-1220
   Abstract »    Full Text »    PDF »
Fas and Fas ligand in gut and liver.
M. J. Pinkoski, T. Brunner, D. R. Green, and T. Lin (2000)
Am J Physiol Gastrointest Liver Physiol 278, G354-G366
   Abstract »    Full Text »    PDF »
Differential Regulation and Function of Fas Expression on Glial Cells.
S. J. Lee, T. Zhou, C. Choi, Z. Wang, and E. N. Benveniste (2000)
J. Immunol. 164, 1277-1285
   Abstract »    Full Text »    PDF »
Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival.
W.-P. Min, R. Gorczynski, X.-Y. Huang, M. Kushida, P. Kim, M. Obataki, J. Lei, R. M. Suri, and M. S. Cattral (2000)
J. Immunol. 164, 161-167
   Abstract »    Full Text »    PDF »
Fas and Fas ligand expression in cystic fibrosis airway epithelium.
I. Durieu, C. Amsellem, C. Paulin, M.-T. Chambe, J. Bienvenu, G. Bellon, and Y Pacheco (1999)
Thorax 54, 1093-1098
   Abstract »    Full Text »
Induction of Allograft Tolerance in the Absence of Fas-Mediated Apoptosis.
X. C. Li, Y. Li, I. Dodge, A. D. Wells, X. X. Zheng, L. A. Turka, and T. B. Strom (1999)
J. Immunol. 163, 2500-2507
   Abstract »    Full Text »    PDF »
Microglial Activation Varies in Different Models of Creutzfeldt-Jakob Disease.
C. A. Baker, Z. Y. Lu, I. Zaitsev, and L. Manuelidis (1999)
J. Virol. 73, 5089-5097
   Abstract »    Full Text »
Dissecting Fas signaling with an altered-specificity death-domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation.
H. Y. Chang, X. Yang, and D. Baltimore (1999)
PNAS 96, 1252-1256
   Abstract »    Full Text »    PDF »
Human Melanoma Cells Do Not Express Fas (Apo-1/CD95) Ligand.
D. B. Chappell, T. Z. Zaks, S. A. Rosenberg, and N. P. Restifo (1999)
Cancer Res. 59, 59-62
   Abstract »    Full Text »    PDF »
Transforming Growth Factor-beta 1 Suppresses Serum Deprivation-induced Death of A549 Cells through Differential Effects on c-Jun and JNK Activities.
Y. Huang, D. Hutter, Y. Liu, X. Wang, M. S. Sheikh, A. M-L. Chan, and N. J. Holbrook (2000)
J. Biol. Chem. 275, 18234-18242
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)